Stock screener

ABEO

Conviction 69HealthcareScan · Thu, Jun 25, 2026
ABEO$5.56-1.16%
ResistanceSupportVol 14Insider sell
63 bars
5
4
Vol MA14 1.16M
Mar 26Apr 14May 1May 19Jun 8Jun 25
ABEONA THERAPEUTICS INC.PHARMACEUTICAL PREPARATIONSwww.abeonatherapeutics.com
Price5.56
Change-1.16%
Gap+0.89%
Rel volume1.77×
Avg volume1.04M
Avg $ vol5.84M
SMA 205.62
SMA 505.58
SMA 2005.21
Price vs 50-0.39%
Price vs 200+6.56%
MA stackmixed
50/200 cross
Supertrenddown · 6.05
RSI (14)49
MACD hist-0.00
MACD crossbear · 0d
Stoch %K / %D49 / 57
ADX (14)12
+DI / −DI18 / 18
RSI divergence
MACD divergence
ATR %+4.08%
ADR %3.88%
52w high7.23
52w low4.17
From 52w high-23.17%
Above 52w low+33.21%
New 52w highNo
SqueezeOn · 12d
Bollinger width9.44%
%B0.37
Donchian pos44.68%
Donchian high5.95
Donchian low5.24
AVWAP (52w high)5.20
vs AVWAP high+6.78%
AVWAP (52w low)5.08
vs AVWAP low+9.41%
OBV trendDown
Chaikin MF (20)-0.27
Today vs 20d1.77×
Avg vol (14d)1.16M
Avg vol (20d)1.04M
Avg $ vol (20d)5.84M
Market cap316.61M
RS 3m (vs SPY)+17.54%
RS 6m (vs SPY)+2.24%
RS line new highNo
Trend template4/8
Technical rank51.1
1 week-1.68%
1 month+1.18%
3 months+25.68%
6 months+2.11%
1 year-5.20%
YTD+4.61%
P/E4.45
P/B2.18
P/S54.40
P/FCF-3.76
EPS1.01
Div yield
ROE49.11%
ROA35.86%
Debt/Eq0.12
Current5.89
EV/EBITDA-3.15
Gross margin
Net margin
Rev growth66.29%
EPS growth211.69%
Price target19.75
Target upside255.54%
Analyst ratingBuy
Institutional74.18%
Ent. value273.32M
Revenue8.72M
Net income-17.07M
Gross profit
Free cash flow-84.3M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out57M
Employees226
ListedFri, Sep 19, 1980
Free float48.09M
Float %88.7%
Short interest14.39M
Days to cover16.4d
Short volume62.6%
Squeeze score92 / 100
Next earnings
EPS forecast
Last EPS vs est−$0.30 vs −$0.33
Last surprise+9.1% beat
Setup gradeB
Conviction69 / 100
Pattern quality
Tech rank51.1 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance6.04
Support5.16
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ABEO

All disclosures →
No recent disclosed trades by Congress in ABEO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ABEO · 10 sells

InsiderSideShares
Vasanthavada Madhav
Chief Commercial Officer · Common Stock · 2026-06-16
Dispose222
Seshadri Vishwas
Chief Executive Officer · Common Stock · 2026-06-09
Sell31.92K
Vazzano Joseph Walter
Chief Financial Officer · Common Stock · 2026-06-09
Sell25.65K
O'Malley Brendan M.
SVP, Chief Legal Officer · Common Stock · 2026-06-09
Sell6.3K
Vazzano Joseph Walter
Chief Financial Officer · Common Stock · 2026-06-09
Sell13.42K
Vasanthavada Madhav
Chief Commercial Officer · Common Stock · 2026-06-09
Sell5.45K
Vasanthavada Madhav
Chief Commercial Officer · Common Stock · 2026-06-08
Sell4.17K
Seshadri Vishwas
Chief Executive Officer · Common Stock · 2026-06-08
Sell24.43K
Vazzano Joseph Walter
Chief Financial Officer · Common Stock · 2026-06-08
Sell10.27K
O'Malley Brendan M.
SVP, Chief Legal Officer · Common Stock · 2026-06-08
Sell4.83K

SEC filings

EDGAR filings in ABEO · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.